HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanjeev Giri Selected Research

EDBA

4/2022Exploration of the Plausible Mechanism of Ethambutol Induced Ocular Toxicity by Using Proteomics Informed Physiologically Based Pharmacokinetic (PBPK) Modeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sanjeev Giri Research Topics

Disease

3Neoplasms (Cancer)
09/2022 - 07/2011
2Pruritus (Itching)
07/2020 - 01/2020
1Optic Nerve Diseases (Optic Neuropathy)
04/2022
1Toxic Optic Neuropathy
04/2022
1Tuberculosis (Tuberculoses)
09/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2020
1Hematologic Neoplasms (Hematological Malignancy)
12/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2020
1Hypercholesterolemia
07/2020
1Myalgia
07/2020
1Acne Vulgaris
07/2020
1Obesity
07/2020
1Arthritis (Polyarthritis)
07/2020
1Blister (Bulla)
07/2020
1Erythema
07/2020
1Headache (Headaches)
07/2020
1Allergic Rhinitis
01/2020
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2020
1Urticaria (Hives)
01/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2019
1Dyslipidemias (Dyslipidemia)
03/2017

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
12/2020 - 07/2011
1EDBAIBA
04/2022
1Ethambutol (Myambutol)FDA LinkGeneric
04/2022
1MetalsIBA
04/2022
1Isoniazid (Ftivazide)FDA LinkGeneric
09/2021
1CA-4948IBA
12/2020
1guggulu extractIBA
07/2020
1Ophthalmic Solutions (Eye Drops)IBA
01/2020
1SaltsIBA
01/2020
1acalabrutinibIBA
02/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
02/2019
1glimepiride (Amarel)FDA LinkGeneric
03/2017
1pitavastatin (itavastatin)FDA Link
03/2017
11- (1- (2- amino- pyridin- 4- ylmethyl)- 1H- indol- 4- yl)- 3- (5- bromo- 2- methoxyphenyl)ureaIBA
07/2011

Therapy/Procedure

1Therapeutics
09/2022